Session 2: Challenges facing the computational biology of cancer sequencing
Go back to the summary of the CRI symposium.Overall summary: Is it possible to move the goal-posts and say that a clinical “test†no longer revolves around the actual sequencing of a cancer gene, as in the case of BRCA1/2 screening, but is now more […]